Method for treating patients with puerperal neuroendocrine syndrome

FIELD: medicine, gynecology.

SUBSTANCE: the present innovation deals with treating puerperal obesity-manifesting neuroendocrine syndrome. The method includes fractional nutrition, terrencur per 7.8-8.5 km/d, mineral baths and gynecological irrigations at applying hydrocarbonate-sulfate sodium-calcium mineral water of Slavyanovski well of 35-38°. During the whole course of therapy it is necessary to have the intake of the same mineral water thrice daily about 30-40 min before meals. One should carry out acupuncture reflexotherapy due to the second brake method during maximal activity of renal canals, those of urinary bladder, liver and pancreas. Acupuncture reflexotherapy should be alternated according to the days of affecting key points, group LO of "magic meridians", "key points" on the main syndrome. The innovation improves therapeutic result due to affecting autonomic nervous system.

EFFECT: higher efficiency of therapy.

3 ex, 1 tbl

 

The invention relates to medicine, namely, gynecology, and for the treatment of women suffering from postpartum neuroendocrine syndrome, and can be used in the health clinics.

In recent decades there has been an increase of these diseases involving disorders of the menstrual cycle and fertility reduction that determines their medical and social importance.

A special form of endocrine pathology, accompanied by menstrual and reproductive function with increasing body mass after pregnancy or childbirth, was described Wenstrom in 1970 and named the author of postpartum neuroendocrine syndrome (PRES).

Finding new methods of treatment of PNES remains one of the topical problems in gynecology, given polietiologichesky nature of the disease, its rapid development, frequent resistance to drug therapy. In this regard, great interest is the use of alternative therapies, contributes to the activation of the natural mechanisms of self-regulation.

Known methods of treatment of postpartum neuroendocrine syndrome with the use of baths and gynecological irrigation hydrocarbonate-sulphate-sodium-calcium mineral water Slavyanovskaya source, the temperature of 36-38°C, Expo is ice each procedure - 15 minutes, at the rate of 8-12 treatments. Throughout the course of sanatorium-resort treatment is internal reception of the same mineral water 3 times a day for 40-60 minutes before eating 3-5 ml per 1 kg of body weight. Training regime, diet (nutrition fractional), and the path 7.8-8.5 km per day, the angle of elevation 0-10° (Urvacheva E.E., Grechkin B.C., 2005), given that the mineral water, affecting various physiological systems of the body and especially in his General reactivity and the level of metabolic processes, mobilizes compensatory and protective mechanisms, contributes to the restoration of disturbed functions. Its therapeutic effect in addition to thermal factor is based on the presence of a large number of active chemical and biological agents, leading to activation of the enzymatic, biochemical, immune processes at the cellular and subcellular levels, resulting in reduced inflammation, increases circulation, improves trophic processes and regeneration. This method of treatment has a positive effect on the menstrual function. However, if after the weight loss and the elimination of menstrual function is not restored ovulatory cycle, the authors recommended the use of other methods of treatment. In addition, the use of the above method gives dolgovremennyi effect. However, balneotherapy finds application in clinical practice, because there are no effective tools for the treatment of this pathology milder effect.

The technical result of the proposed method of treatment of women suffering from PNAS, is the improvement of the General condition, decrease hypertension, improvement of carbohydrate and lipid metabolism, reduction of body weight, reduction of the manifestations of disorders of the autonomic nervous system, improving menstrual and reproductive function, and libido.

This technical result is achieved by the fact that against the background of domestic mineral water and balneotherapy sick appoint additional IRT second braking method according to the method Ararken and Nagarjuna used in the treatment of obesity (1988).

Apply mineral baths and gynecological irrigation using hydrocarbonate-sulphate-sodium-calcium mineral water Slavyanovskaya source, the temperature of 36-38°S, the exposure time of each treatment 15 minutes, at the rate of 8-12 treatments. Throughout the course of sanatorium-resort treatment is internal reception of the same mineral water 3 times a day for 40-60 minutes before eating 3-5 ml per 1 kg of body weight. Training regime, diet (nutrition fractional 5-6 times a day), path 7.8-8.5 in the m a day, elevation 0-10°and IRT methodology Ararken and Nagarjuna used in the treatment of obesity (1988). Acupuncture was the selection of points with alternating days of influences on point "keys" and group LO "wonderful meridians". The point of the "keys" on the main syndrome. Procedures were performed daily for the course of 8-10, the second brake method.

The method is performed as follows. The treatment is 18-24 days. Patients designate mineral baths and gynecological irrigation with mineral water Slavyanovskaya source Zheleznovodsk type temperature 36-38°S, the exposure time of each procedure is 10-15 minutes, at the rate of 8-12. Procedures patients receive mode: 2-3 days reception - 1 day break or every other day. Throughout the course of sanatorium-resort treatment is internal reception of the same mineral water 3 times a day for 45 minutes before a meal 3-5 ml per 1 kg of body weight. The food was fractional - 5-6 times a day. Applied physical activity in the form of path 7.8-8.5 km per day, the angle of elevation 0-10°. Acupuncture was administered according to the methods Ararken and Nagarjuna used in the treatment of obesity (1988). Acupuncture was to use points with alternating days of influences on point "keys" and group LO "wonderful meridians". The point of the "keys" on the main syndrome. Procedures conducted the camping daily at the rate of 8-10, the second brake method, at the time of maximum activity of the channels (kidney, bladder, liver, pancreas, respectively).

The method is illustrated by the following examples.

Example 1. Patient IV Diagnosis: Postpartum neuroendocrine syndrome. Oligomenorrhea. Complaints about irregular menstruation with delay of 1 month, the progressive increase of body weight after childbirth. Anthropometric data: height - 160 cm, weight 116 kg, CG - 119 cm, 110 cm, ABOUT - 137 see Objective data: the patient high power fat deposits mainly in the neck, arms, abdomen, thighs. On the skin of the chest, abdomen and thighs multiple striae. Gynecological status: cervix cylindrical shape, without pathology. The uterus and appendages without features. Studies: clinical blood and urine tests - without a pathology. ECG - hypertrophy of the muscles of the left ventricle. Violation of repolarization in the back wall of the left ventricle (nonspecific). Ultrasound of the pelvic organs - echoes-signs of chronic bilateral oophoritis. Lipid metabolism blood (total lipids, triglycerides, (β-lipoproteins, phospholipids) - all parameters increased. The sugar content in the blood is increased, liver function tests, prothrombin index is normal. Cytological smear of the vulva without atypia, with the cervix and cervical canal without pathologies smears on the purity of the vaginal flora - gonorrhoea is not detected, there is coccal flora in large quantities, leukocytes - 8-10 in the field of view. Research on specific infections (chlamydia, mycoplasmosis, ureaplasmosis, Gardnerella) - negative.

Treatment. The complex treatment consisted of assigning a fractional power on diet No. 15, exercise (path), mineral baths (37°C, 15 min), gynecological irrigation mineral water (37°C, 15 min). All procedures were performed in one day, one day, on a course of 10 treatments. In addition, daily RTI conducted on the above methodology Ararken and Nagarjuna on a course of 8 treatments.

After receiving the specified complex treatment decreased body weight. Menstrual function is normalized. After treatment: weight - 108 kg, CG - 117 cm, 108 cm - 130 cm

Clinical blood and urine tests within normal limits, the degree of purity of the vaginal flora - I. Lipid metabolism blood: the content of total lipids was slightly increased, all other indicators declined. The patient was discharged with improvement in General condition, gynecological status.

Summary. Thus, the patient received in the clinic treatment of RTIs, mineral baths and gynecological irrigation, bore the procedure well, negative side effects were not. The effect was observed within 6 months. Menstrual function was regular the th 10 months. After 6 months weight gradually began to increase, and the cycle has again become irregular.

Example 2. Patient IV Diagnosis: Postpartum neuroendocrine syndrome. Infertility secondary. Complaints of lower abdominal pain in the first day of menstruation or after exposure to cold, the progressive increase of body weight after childbirth.

Anthropometric data: height is 156 cm, weight 72 kg, CG - 101 cm - 88 cm, ABOUT - 105 see Data of objective examination: the patient high power fat deposits mainly in the abdomen and hips. The skin of the abdomen multiple striae. Studies: clinical blood and urine tests - without a pathology. ECG sinus Rhythm of 70 in 1 minute with the transition in sinus tachycardia up to 100 in 1 minute. Local disturbance of intraventricular conduction. Signs of early repolarization of the left ventricle. The sugar content in the blood is increased, prothrombin index is increased. Cytological smear of the vulva without atypia. Smears on the purity of the vaginal flora - gonorrhea is not detected, there is a rod flora in large quantities, leukocytes - 10-12 in the field of view. Research on specific infections (chlamydia, mycoplasmosis, ureaplasmosis, Gardnerella) - negative.

Treatment. The complex treatment consisted of assigning a fractional power on diet No. 15, exercise (path), mineral baths (37°C, 15 min), gin is n irrigation mineral water (37° C, 15 min). All procedures were performed in one day, one day, on a course of 10 treatments. In addition, every day was held IRT methodology Ararken and Nagarjuna on a course of 8 treatments.

After receiving the specified complex treatment decreased body weight. Weight after treatment - 68 kg, OG - 99 cm, 86 cm, ABOUT - 103 see

Clinical blood and urine tests within normal limits, the degree of purity of the vaginal flora. the Patient was discharged with improvement in General condition, gynecological status, reduce body weight by improving menstrual function. After 1 month, the patient became pregnant.

Summary. Thus, the patient received in the clinic treatment of RTIs, mineral waters, bore the procedure well, negative side effects were not. As a result of treatment was observed pregnancy, testified to normalize the function of the ovary.

Example 3. Patient O.E. Diagnosis of Neuroendocrine syndrome. Chronic bilateral salpingo-oophoritis in remission. Oligomenorrhea. Complaints about irregular menstruation with delays in 7-10 days, the progressive increase of body weight after honey. the abortion.

Anthropometric data: height - 158 cm, weight 75 kg, CG - 111 cm, 91 cm, ABOUT - 104 see Data of objective examination: the patient high power fat deposits mainly in the neck, arms, abdomen. Skin W is the Voth, breast, multiple striae. Studies: clinical blood and urine tests - without a pathology. ECG - signs of violations of repolarization in the back wall of the left ventricle. The sugar content in the blood is increased, prothrombin index is normal. Cytological smear of the vulva without atypia. Smears on the purity of the vaginal flora - gonorrhea is not detected, there is a rod flora in large quantities, leukocytes - 3-4 in eyeshot. Research on specific infections (chlamydia, mycoplasmosis, ureaplasmosis, Gardnerella) - negative.

Treatment. The complex treatment consisted of assigning a fractional power on diet No. 5, exercise (path), mineral baths (37°C, 15 min), gynecological irrigation mineral water (37°C, 15 min). All procedures were performed in one day, one day, on a course of 10 treatments. In addition, every day was held IRT methodology Ararken and Nagarjuna on a course of 8 treatments.

After receiving the specified complex treatment decreased body weight. Weight after treatment 69 kg

Clinical tests after treatment of blood and urine within limits, the degree of purity of the vaginal flora. the Patient was discharged from the clinic with the improvement of the General condition, decrease in body weight gynecological status, improvement of menstrual function. After 1 year, the patient was called in to re-obsledovanie treatment at the clinic. She notes that throughout the year after a balneotherapy cycle was regular, weight - stable.

Summary. Thus, the patient received in the clinic treatment of RTIs, mineral waters, bore the procedure well, negative side effects were not. As a result of treatment were observed normalization of ovarian function.

In this way in Zheleznovodsk clinic Pyatigorsk Institute of balneology was treated 56 patients suffering from menstrual function, developed on the background of postpartum neuroendocrine syndrome. The time of stay of patients in both groups at the clinic was 23.2 per day. The control group consisted of 66 people who received course only balneotherapy. Both groups in clinical terms were representative. All patients complained of menstrual dysfunction and the absence of pregnancy. All women were higher physique. Obesity was mainly abdominal 72% of patients, gluteofemoral with 28% of the persons most (78,1%) patients BMI was in the range of 31-40 kg/m2. Mainly observed complex vascular and psycho-emotional disorders. The evaluation of the functional state of the Central parts of the reproductive system method EEG was performed for all patients. Revealed diffuse changes of bioelectric AK is Yunosti brain mainly related to pathology of deep structures, i.e. study testified to the presence of dysfunction mesodiencephalic structures. According to the gynecological examination and sonography inflammation of the uterus was observed in 61.8% of patients; the presence of adhesions at 49.2 percent. The structure of the endometrium and ovary was not changed at 17.3% of patients. In 14.6% of cases atresia of follicles, 36,1% discovered polycystic changes in the ovaries, 12.5% diagnosed with hypoplastic uterus.

Treatment effectiveness was assessed by subjective and objective indicators. Reduction of menstrual cycle was observed in the main and control groups, respectively, 67 and 52%. Regular menstrual function was restored at 48.7 percent, of which the basal temperature was biphasic in the treatment of 33.3%. It can be stated that significantly better dynamics of clinical manifestations obtained by applying the main complex. The use of combined treatment contributed more pronounced (18%) reduction of body weight, on average, 7.8±0.5 kg (p<0,05).

Both complexes unilaterally had a positive impact on the health of women, reducing irritability, anxiety, sweating, but to a much greater extent contributed to the reduction of headaches, is normalisatie sleep due to a more pronounced action on the autonomic nervous system complex including RTI.

Table

Effect of mineral water on body mass index and the presence of menstrual disorders in women suffering from neuroendocrine syndrome (n=37)
OptionsTo

treatment
After the treatmentP
The body mass index (kg/m2)

I gr. (n=56)
34,45±0,4028,63±0,21<0,05
The body mass index (kg/m2)

II gr. (n-66)
34,91±0,3631,13±0,44<0,05
The presence of impaired ovarian-menstr. f (%)

I gr. (n=56)
10033<0,05
The presence of impaired ovarian-menstr. f (%)

II gr. (n=66)
10048<0,05

Electroencephalographic studies conducted in patients of the main group, showed a decrease medlennovolnova and normalization of the amplitude of the activity indicators. Severity α-rhythm has improved the reactivity of the cerebral cortex was normal and happened optimization interhemispheric correlations in 91.8% of cases.

Thus, taking into account the influence of iglorefleksoterapii disturbed the original function body is in and of systems in this category of patients and the absence of pathological changes due to the ongoing impact of the applied treatment, including RTIs, mineral baths, gynecological irrigation is pathogenetically justified treatment method at the stage of sanatorium-resort treatment.

The method of treatment of postpartum neuroendocrine syndrome, manifested by obesity, characterized in that assign a fractional power, carry out a training regime that includes a path 7.8-8.5 km per day, conduct mineral baths and gynecological irrigation using hydrocarbonate-sulphate-sodium-calcium mineral water Slavyanovskaya source temperature of 36-38°when the exposure of each procedure 15 min, in the course of 8-12 procedures and conduct during the entire course of treatment receive the same mineral water 3 times a day for 30-40 minutes before a meal 3-5 ml per 1 kg of body weight, as well as conduct acupuncture second brake method at the time of maximum activity of the channels of the kidneys, bladder, liver, pancreas interleaved by day effects on point-keys, group LO "wonderful meridians", "point-keys on the main syndrome".



 

Same patents:

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to novel compounds of the formula (I) and their pharmaceutically acceptable salts and/or pharmaceutically acceptable esters. Proposed compounds possess properties of agonists of receptors activated by peroxisome proliferators (PPAR agonists) and can be used in treatment of such diseases as diabetes mellitus, hypertension, atherosclerotic diseases and others. In the general formula (I) R1 represents phenyl, optionally mono-, di- or tri-substituted with halogen atom, lower alkyl, fluorine-lower alkyl, lower alkoxy-group; R2 represents hydrogen atom or lower alkyl; R3 and R4 represents independently of one another hydrogen atom, hydroxy-group, halogen atom, lower alkyl, fluorine-(lower alkyl), lower alkoxy-group wherein at least one of radicals R3 and R4 doesn't represent hydrogen atom; R5 represents lower alkoxy-group; R6 represents hydrogen atom or lower alkyl; n = 1. Also, invention relates to a pharmaceutical composition based on compounds of the invention.

EFFECT: valuable medicinal properties of compounds.

19 cl, 1 tbl, 7 sch, 56 ex

FIELD: medicine.

SUBSTANCE: the present innovation refers to compositions for maintaining cardio-vascular system and/or vessels in healthy state, moreover, they contain efficient quantity of monomer and/or oligomer of cacao procyanidin and efficient quantity of cholesterol-decreasing reagent based upon sterol and/or stanol, and it, also, refers to the methods to maintain vascular system in healthy state including therapy and prophylaxis of atherosclerosis and cardio-vascular disease. The innovation provides enhanced impact upon the state of mammalian cardio-vascular system, human cardio-vascular system, in particular, against previously known compositions at treating and preventing atherosclerosis and cardio-vascular diseases.

EFFECT: higher efficiency.

38 cl, 8 dwg, 6 ex, 7 tbl

FIELD: synthesis of biologically active compounds.

SUBSTANCE: invention provides 1,5-benzothiazepines of general formula I (formulae presented below), in which Rv and Rw are independently selected from hydrogen and C1-C5-alkyl; one of Rx and Ry represents hydrogen or C1-C6-alkyl and the other hydroxy or C1-C6-alkoxy; Rz is selected from halogen, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulfamoyl, C1-C6-alkyl, and other residues indicated in claim 1 of invention; v is a number from 0 to 5; one of R4 and R5 represents group of general formula IA; R3 and R6 and the second from R4 and R5 are independently selected from hydrogen, halogen, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulfamoyl, C1-C6-alkyl, and other residues indicated in claim 1; R3 and R6 and the second from R4 and R5 being optionally substituted by one or several R16 groups at their carbon atoms; D represents -O-, -N(Ra)-, -S(O)b- or -CH(Ra)-, wherein Ra is hydrogen or C1-C6-alkyl; and b=0-2; ring A represents aryl or heteroaryl and is optionally substituted by one or several substituents selected from R17; R7 represents hydrogen, C1-C4-alkyl, carbocyclyl, or heterocyclyl and is optionally substituted by one or several substituents selected from R18; R8 represents hydrogen or C1-C4-alkyl; R9 represents hydrogen or C1-C4-alkyl; R10 represents hydrogen or C1-C4-alkyl, carbocyclyl, or heterocyclyl and is optionally substituted by one or several substituents selected from R19; R11 represents carboxy, sulfo, sulfino, phosphono, tetrazolyl, -P(O)(ORc)(ORd), -P(O)(OH)(ORc), -P(O)(OH)(Rd), or -(O)(ORc)(Rd), wherein Rc and Rd are independently selected from C1-C6-alkyl; or R11 represents group of general formula IB, in which X is -N(Rq)-, N(Rq)C(O)-, -O-, or -S(O)a, wherein a=0-2; and Rq is hydrogen or C1-C4-alkyl; R12 represents hydrogen or C1-C4-alkyl; R13 and R14 are independently selected from hydrogen, C1-C4-alkyl, carbocyclyl, heterocyclyl, or R23, of which C1-C4-alkyl, carbocyclyl, heterocyclyl, or R23 can be optionally independently substituted by one or several substituents selected from R20; R15 represents carboxy, sulfo, sulfino, phosphono, tetrazolyl, -P(O)(ORe)(ORf), -P(O)(OH)(ORe), -P(O)(OH)(Re), or -P(O)(ORe)(Rf), wherein Re and Rf are independently selected from C1-C6-alkyl; or R15 represents group of general formula IC, in which R24 is selected from hydrogen and C1-C4-alkyl; R24 is selected from hydrogen, C1-C4-alkyl carbocyclyl, heterocyclyl, and R27, of which C1-C4-alkyl, carbocyclyl, heterocyclyl, or R27 can be optionally independently substituted by one or several substituents selected from R28; R26 is selected from carboxy, sulfo, sulfino, phosphono, tetrazolyl, -P(O)(ORg)(ORh), -P(O)(OH)(ORg), -P(O)(OH)(Rg), or -P(O)(ORg)(Rh), wherein Rg and Rg are independently selected from C1-C6-alkyl; p=1-3; wherein meanings for R13 can be the same or different; q=0-1; r=0-3; wherein meanings for R14 can be the same or different; m=0-2; wherein meanings for R10 can be the same or different; n=1-3; wherein meanings for R7 can be the same or different; z=0-3; wherein meanings for R25 can be the same or different; R16, R17, and R18 are independently selected from halogen, nitro, cyano, hydroxy, carbamoyl, mercapto, sulfamoyl, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkoxy, C1-C4-alkanoyl, C1-C4-alkanoyloxy, N-(C1-C4-alkyl)amino, N,N-(di-C1-C4-alkyl)amino, C1-C4-alkyl-S(O)a (wherein a=0-2), C1-C4-alkoxycarbonyl, N-(C1-C4-alkyl)sulfamoyl, and N,N-(di-C1-C4-alkyl)sulfamoyl; wherein R16, R17, and R18 can be optionally independently substituted by one or several of R21 at their carbon atoms; R19, R20, R23, R27, and R28 are independently selected from halogen, nitro, cyano, hydroxy, carbamoyl, mercapto, sulfamoyl, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkoxy, C1-C4-alkanoyl, C1-C4-alkanoyloxy, N-(C1-C4-alkyl)amino, N.N-(di-C1-C4-alkyl)amino, C1-C4-alkanoylamino, N-(C1-C4-alkyl)carbamoyl, N,N-(di-C1-C4-alkyl)carbamoyl, C1-C4-alkyl-S(O)a (wherein a=0-2), C1-C4-alkoxycarbonyl, N-(C1-C4-alkyl)sulfamoyl, N,N-(di-C1-C4-alkyl)sulfamoyl, carbocyclyl, heterocyclyl, sulfo, sulfino, amidino, phosphono, -P(O)(ORa)(ORb), -P(O)(OH)(ORa), -P(O)(OH)(Ra), or -P(O)(ORa)(Rb), wherein Ra and Rb are independently selected from C1-C6-alkyl and wherein R19, R20, R23, R27, and R28 can be optionally independently substituted by one or several of R22 at their carbon atoms; R21 and R22 are independently selected from halogen, hydroxy, cyano, carbamoyl, mercapto, sulfamoyl, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, ethoxy, vinyl, allyl, ethynyl, methoxycarbonyl, formyl, acetyl, formamido, acetylamino, acetoxy, methylamino, dimethylamino, N-methylcarbamoyl, N,N-dimethylcarbamoyl, methylthio, methylsulfinyl, mesyl, N-methylsulfamoyl, N,N-dimethylsulfamoyl; or pharmaceutically acceptable salt thereof, solvate, or salt solvate. Described are also method for preparing compounds of formula I, pharmaceutical compositions based on compounds I, and a method for achieving inhibiting effect relative to interscapular brown adipose tissue (IBAT), and intermediates. (I), (IA), (IB), (IC).

EFFECT: expanded synthetic possibilities in the 1,5-benzothiazepine series.

36 cl, 121 ex

FIELD: medicine, clinical pharmacology, restoring therapy.

SUBSTANCE: the suggested preparation is being a lipid fraction isolated out of a king crab's liver Paralithodes comtschatica that contains 10% polyunsaturated fatty acids, 10% alkyl-diacyl glycerides and the complex of natural bioantioxidants being of highly correcting, hypocoagulative and antioxidant properties. The preparation suggested enables to widen the quantity of food BAA of natural origin of lipid-correcting action at pronounced hypocoagulative and antioxidant properties based upon application of natural lipid complex. It could be applied as an efficient means of prophylaxis of cardio-vascular diseases and other pathologies, when lipid exchange is broken and which is accompanied with disorders of hemocoagulation and intensification of lipoperoxidation process.

EFFECT: higher efficiency.

1 ex, 4 tbl

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to novel compounds of the formula (I): wherein A1 means hydrogen atom (H), halogen atom, (C1-C5)-alkyl, group of the formula (a): ; A2 means (C1-C5)-alkyl, (C1-C5)-alkoxyl chain, (C1-C5)-alkenyl, hydroxy-(C1-C5)-alkyl, carbonyl-(C1-C5)-alkyl; A3 means halogen atom or group of the formula (a); A4 means (C1-C5)-alkyl, H, halogen atom, -COOR1, (C1-C5)-alkoxy-group, group of the formulae (a) and (b): wherein R1 means hydrogen atom, (C1-C5)-alkyl; R2 means -CH2OH, -COOR1; R3 means -OH, -OC(O)-R1; R4 means -(CH2)k-R5(CH2)l-; R5 means a simple bond (-), -CH=CH-, -OCH2-, carbonyl group or -CH(OH)-, and R4 is bound with tetrahydropyrane ring by the carbon-carbon bond; k and l = 0, 1 or a whole number above 1; k + l = 10 or lesser number; n = 0 or 1; p, g, r = 0 being one value among A1, A3 and A4 in the formula (I) must represent group of the formula (a), or to their pharmaceutically acceptable salts. Also, invention describes method for synthesis of proposed compounds. Proposed compounds of the formula (I) can be used as hypocholesterolemic agents for decreasing the serum blood cholesterol level.

EFFECT: valuable medicinal properties of compounds and pharmaceutical composition, improved method of synthesis.

5 cl, 3 tbl, 35 ex

FIELD: chemistry of heterocyclic compounds, medicine, pharmacy.

SUBSTANCE: invention relates to novel heterocyclic compounds of the general formula (I): wherein R1 represents hydrogen atom or (C1-C6)-alkyl; R2 represents hydrogen atom, -CO-R3 wherein R3 represents (C2-C6)-alkyl substituted optionally with halogen atom, -CO-C(R4)=C(R4)-R5 wherein R4 represents hydrogen atom or (C1-C4)-alkyl; R5 represents (C1-C8)-alkyl, (C2-C8)-alkenyl and others; Y represents compound of the formula: wherein R7 represents hydrogen atom or (C1-C4)-alkyl; R8 represents (C5-C8)-alkyl, (C4-C8)-cycloalkyl and others; X represents oxygen atom or sulfur atom and others. Also, invention relates to pharmaceutically acceptable salts of these compounds. Compounds of the formula (I) possess hypoglycemic and/or hypolipidemic activity and can be used in medicine in treatment of diabetes mellitus, hyperlipidemia, hyperglycemia, diseases caused by resistance to insulin and other diseases.

EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.

28 cl, 3 tbl, 131 ex

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to novel compounds represented by the general formula (I): and their pharmaceutically acceptable salts and esters possessing agonistic activity with respect to peroxisome proliferator receptors PPARα and/or PPARγ, to a pharmaceutical composition based on thereof and their using for preparing medicines wherein R1 means thiophenyl or phenyl optionally substituted with from one to three substitutes chosen independently from halogen atom, (C1-C8)-alkoxy-group, (C1-C8)-alkyl and (C1-C8)-alkyl substituted with one-three halogen atoms; R2 means hydrogen atom or (C1-C8)-alkyl; R3 means phenoxy-, (C2-C8)-alkenyloxy- or (C1-C8)-alkoxy-group; R4 means hydrogen atom or (C1-C8)-alkyl wherein one of substitutes R5 and R6 means compound of the formula and another one means hydrogen atom and wherein the bond between carbon atoms Ca and Cb means a carbon-carbon simple or double bond; R7 means hydrogen atom or (C1-C8)-alkyl; R8 means hydrogen atom or (C1-C8)-alkyl being any of A and A1 means nitrogen atom and another means oxygen or sulfur atom; n means 1, 2 or 3.

EFFECT: valuable medicinal properties of compound and pharmaceutical composition.

30 cl, 1 tbl, 14 sch, 86 ex

FIELD: medicine.

SUBSTANCE: the suggested innovation deals with introducing the compound (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-yl](3R,5S)-3.5-dihydroxy-hept-6-enic acid (rosuvastatin) or its pharmaceutically acceptable salt that enables to achieve curative effect of applying rosuvastatin only.

EFFECT: higher efficiency of application.

20 cl, 1 dwg, 3 ex, 1 tbl

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to medicaments, namely, to a pharmaceutical composition used in treatment of hypercholesterolemia and hyperlipidemia. Pharmaceutical composition comprises micronized atorvastatin calcium and a substance for correcting pH value taken in the amount providing in dissolving this composition in 900 ml of aqueous medium with pH 3 increasing pH of indicated medium to a value as equal or exceeding pKa + 1 for atorvastatin calcium. Also, invention relates to a method for preparing indicated pharmaceutical composition and its using in treatment of hypercholesterolemia and hyperlipidemia. Invention provides enhancing bioavailability of atorvastatin based on increasing its solubility in aqueous media.

EFFECT: improved and valuable pharmaceutical properties of medicament.

19 cl, 6 ex

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to dibenzylamine compounds of the formula (1): wherein each among R1 and R2 represents (C1-C6)-alkyl group optionally substituted with halogen atoms and so on; each among R3, R4 and R5 represents hydrogen atom, halogen atom and so on, either R3 and R4 in common with carbon atoms bound to them can form a carbocyclic or heterocyclic ring optionally having a substitute (substitutes); A represents -N(R7)(R8) and so on; ring B represents aryl group or heterocyclic residue; R6 represents hydrogen atom, halogen atom, (C1-C6)-alkyl group and so on; n means a whole number from 1 to 3, or its pharmaceutically acceptable salt. Proposed compounds elicit the selective and strong inhibitory effect on CETP activity and can be used as therapeutic or prophylactic agents against hyperlipidemia or arteriosclerosis. Also, the proposed compound can be used with other pharmaceutical agent or some pharmaceutical agents simultaneously against hyperlipidemia or arteriosclerosis. Invention provides the development of a pharmaceutical composition based on dibenzylamine compounds used in treatment or prophylaxis of hyperlipidemia or arteriosclerosis.

EFFECT: valuable medicinal properties of compound and pharmaceutical composition.

25 cl, 40 tbl, 174 ex

FIELD: medicine.

SUBSTANCE: method involves prescribing drinking radon-containing mineral water distinguished by radon activity of 185-370 kBq/l in the amount of 100 ml 3 times a day. Then, radon baths are given where radon activity is of 0.75-2.25 kBq/l, temperature is 36-37°C, procedure duration is 10-15 min. Then, vacuum depression of 4-9 atm with succession frequency of 15-25 pulses per 1 min and alternating sinusoid current of 100-200 Hz, current intensity of 20-40 mA and duration of 12-15 min is applied to kidney region and injured ureter segment region in everyday mode with 10-12 procedures long treatment course.

EFFECT: increased stimulated action to functional renal pacemaker and neuromuscular apparatus; higher percent of stone excretion.

4 cl

FIELD: medicine.

SUBSTANCE: method involves carrying out vacuum massage of prostate with an apparatus. Tampons with 40-45°C hot sulfide mud taken from Sucsun pond are additionally rectally introduced for 20-30 min. The total treatment course is 8-10 procedures long. Daily microenemas are prescribed with mineral water at 36°C in a 10 procedures long course.

EFFECT: enhanced effectiveness of treatment.

FIELD: medicine, gynecology.

SUBSTANCE: patients should be suggested to take radon procedures as baths, gynecolopgical irrigations, microenemas, laserotherapy in autoresonance mode at altering frequency of laser apparatus independently against frequency characteristics of human body, at wave length of 0.89 mcm, power of 10 W onto area of uterine projection in case of genital endometriosis and uterine myoma at exposure of 15 min and onto mammary glands in case of diffuse proliferative mastopathies. Impact fields should be chosen by sectors ranged 10-16 per 10-15 sec for each impact field. Local therapy should be conducted about 2.5-3 h after taking radon procedures successively, not earlier. The first stage - baths with malavit at 1:5 dilution at exposure of 15 min. The second stage - after removing the solution out of vagina it is necessary to introduce malavit gel at a tampon for 4-6 h. The whole therapy should be carried out together with internal intake of mineral water 30-60 min before meals thrice daily per 3.5 mg/kg body weight. The innovation enables to achieve prolonged remission, normalize hormonal level in blood and duration of the second phase of the cycle and decrease cholesterol level in blood.

EFFECT: higher efficiency of correction.

1 dwg, 4 ex

FIELD: medicine, gastroenterology.

SUBSTANCE: the present innovation deals with prescribing dietetic nutrition, drinking mineral water and mineral baths for a patient. Additionally, it is necessary to prescribe relaxation therapy at the quantity of 12 procedures in a massage chair for 18 min, moreover, in the course of the first 2 d of therapy the impact should be made in the massage chair only, and during the next days - in the morning the impact is in the massage chair and 2-3 h later - with the help of apparatus "Zen Trainer" for about 15-20 min. The innovation suggested enables to achieve increased ATP level, decreased AMP level, increased energy charge and positive dynamics according the main values of the level and the ratio of nucleotides.

EFFECT: increased efficiency of restorative therapy.

2 ex, 4 tbl

FIELD: medicine, pediatrics.

SUBSTANCE: children should take sulfide baths and for inner intake - warm low-carbonate chloride-hydrocarbonade sodium-calcium water of low mineralization per 100-200 g depending upon patient's age, for 30 d. The innovation provides improved clinical and paraclinical values due to combined intake of sulfide baths, that stimulate nervous centers through vast cutaneous receptor fields, and drinking water of concrete ionic composition and mineralization degree that decreases activity of all enzymatic systems of gastro-intestinal tract, hepatic among them.

EFFECT: higher efficiency of therapy.

2 ex, 3 tbl

FIELD: medicine, physiotherapy, balneotherapy.

SUBSTANCE: one should prescribe a curative complex including calcium pantothenate per 0.1 g thrice daily and balneotherapy with carbonate low-mineralized hydrocarbonate magnesium-sodium-calcium-iron water for inner intake per 200 ml thrice daily 30 min before meals, during 3 wk. The present innovation enables to normalize respiratory ventilation capacity and decrease renal risk due to normalizing phosphorus-calcium exchange and higher content of renewed glutathione that is provided due to synergistic action of calcium pantothenate and mineral water.

EFFECT: higher efficiency of therapy.

1 cl, 1 ex, 3 tbl

FIELD: medicine.

SUBSTANCE: method involves giving mineral water without gas at 18°C temperature in the amount of 200 ml in one dose during 18 days. Water like Konstaninowskaya-1 is administered in the morning and evening time 20 min before taking meals and when going to bed.

EFFECT: enhanced effectiveness of kidney disease treatment.

2 tbl

FIELD: medicine, stomatology.

SUBSTANCE: invention relates to a method for prophylaxis of caries. Method involves every day mouth cavity gargling with natural mineral water with the fluoride content above 1.2 mg/ml during teeth cleansing and after cleansing for 1 min, not less, by course for 7-10 days. In partial case method involves using natural mineral water "Svetloyarskaya" with the fluoride content 1.7 mg/l for prophylaxis of caries in children living in regions with reduced fluoride content in drinking water. Method provides effective prophylaxis of caries excluding toxic effect of trace elements on body presenting in mineral water.

EFFECT: enhanced effectiveness of prophylaxis.

3 cl, 3 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: method involves sequentially administering ultrasonic inhalations with sodium hydrocarbonate alkaline mineralized and boric mineral water with increased fluorine concentration at aerosol flow speed being equal to 5 l/min during 3 min with following olive oil or other kernel oil inhalation. Then laser radiation therapy is applied to skin above left cubital vein with pulse frequency of 80 Hz and C YII-Th IY reflexogenic segmental zones are treated next to it during 5 min on the left dorsal side at pulse succession frequency being equal to 3000 Hz, pulse power of 2 W alternating it every other day with balneological hydrogen sulfide treatments given to boys at hydrogen sulfide concentration of 50-100 mg/l and to girls at hydrogen sulfide concentration of 25-50 mg/l. The total treatment course is 8 balneological treatments and 10 physiotherapy procedures long.

EFFECT: improved adaptive organism capabilities and its tolerance to physical loads.

3 tbl

FIELD: medicine, physiotherapy.

SUBSTANCE: one should prescribe the diet #1, morning exercises, total pearl baths, intake of mineral sulfate-chloride-sodium-magnesium water, manual massage and peloid applications onto area of wide girdle. The impact mentioned should be fulfilled daily at the quantity of 10 procedures. The intake of mineral water mentioned at 6 g/l mineralization should be prescribed thrice daily per 100-150 ml 30 min before meals. Additionally, one should prescribe phytospecies consisting of the following grasses: everlasting, St. John's wort, yarrow, common horsetail and peppermint at the ratio of 3:3:2:2:2, correspondingly per 50 ml thrice daily after meals for 12-14 d. The innovation enables to improve the values of motor-evacuatory function of bile-excretory system, improve biochemical composition of bile, parameters of regional hemodynamics, and, also, improve morphological state of gastric and duodenal mucosa and restore the continuity of mucosal layer.

EFFECT: higher efficiency of therapy.

1 ex, 2 tbl

FIELD: medical engineering.

SUBSTANCE: device has flexible base having one or two layers connected to each other in plasticized condition, with uniform one-piece structure being formed in hardening. The base has convex parts having central openings. The convex parts are separately located on lines intersecting in different directions or being parallel to base lines. Metal needles with thickenings are placed and fixed in the central openings of base convex parts, with needle sharp ends protruding above the base. They are located in the base so that needles of different metals and/or their alloys alternate along each base line of convex parts distribution. Thus the base additionally has holder manufactured as tape or cord having fastening members on their ends, and at least one through hole is available in base body, allowing the holder to be introduced. The hole is arranged in parallel and/or in perpendicular and/or at an angle to working surface plane. The base is optionally shaped as petal with the petals having various radiuses of curvature. The holes are located between petals, on petal ends in base body in this case. The holes are arranged in parallel and/or in perpendicular and/or at an angle to base working surface, allowing the holder to be introduced into them.

EFFECT: enhanced effectiveness of treatment; improved skin surface stimulation.

8 cl, 12 dwg

Up!